tiprankstipranks
Hoth Therapeutics (HOTH)
NASDAQ:HOTH
US Market

Hoth Therapeutics (HOTH) Financial Statements

490 Followers

Hoth Therapeutics Financial Overview

Hoth Therapeutics's market cap is currently $8.77M. The company's EPS TTM is $-1.337; its P/E ratio is -1.43; Hoth Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -66.83K$ 0.00
Operating Income$ -11.11M$ -8.22M$ -7.69M$ -11.07M$ -14.10M
EBITDA$ -11.11M$ 27.13K$ -153.15K$ 0.00$ -14.10M
Net Income$ -12.47M$ -8.19M$ -7.85M$ -11.68M$ -14.31M
Balance Sheet
Cash & Short-Term Investments$ 6.25M$ 7.04M$ 9.29M$ 6.64M$ 10.43M
Total Assets$ 7.60M$ 7.71M$ 10.24M$ 6.76M$ 10.99M
Total Debt$ 5.68K$ 31.07K$ 55.16K$ 0.00$ 0.00
Net Debt$ -6.24M$ -7.01M$ -9.24M$ -6.43M$ -8.54M
Total Liabilities$ 1.45M$ 833.91K$ 704.98K$ 1.64M$ 1.10M
Stockholders' Equity$ 6.15M$ 6.88M$ 9.54M$ 5.12M$ 9.88M
Cash Flow
Free Cash Flow$ -9.80M$ -6.98M$ -8.45M$ -9.37M$ -12.21M
Operating Cash Flow$ -9.80M$ -6.98M$ -8.45M$ -9.30M$ -12.09M
Investing Cash Flow$ -300.00K$ 0.00$ 0.00$ 1.16M$ -165.35K
Financing Cash Flow$ 9.31M$ 4.74M$ 11.32M$ 6.04M$ 18.19M
Currency in USD

Hoth Therapeutics Earnings and Revenue History

Hoth Therapeutics Debt to Assets

Hoth Therapeutics Cash Flow

Hoth Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.